Haemonetics wins FDA approval for PerQseal Elite closure system
Haemonetics Corporation (NYSE: HAE) announced that the U.S. Food and Drug Administration has approved its PerQseal Elite vascular closure system ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

